title: Favorable outcome in a patient with vulvar mucormycosis during acute myeloid leukemia induction with medical management alone.
authors: Karthik
authors: K
authors: Udupa
authors: Prasanth
authors: P
authors: Ganesan
authors: Urmila
authors: U
authors: Majhi
authors: Rejiv
authors: R
authors: Rajendranath
authors: Tenali Gnana
authors: TG
authors: Sagar
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000382:microbiology*; D009091:Mucormycosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D014845:Vulvar Diseases / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology
chemical_list: D000900:Anti-Bacterial Agents; D003561:Cytarabine; D003630:Daunorubicin